Proteomic applications of protein quantification by isotope-dilution mass spectrometry

被引:26
作者
Mayya, Viveka
Han, David K. [1 ]
机构
[1] Univ Connecticut, Ctr Hlth, Dept Cell Biol, Farmington, CT 06030 USA
[2] Univ Connecticut, Ctr Hlth, Ctr Vasc Biol, Farmington, CT 06030 USA
关键词
isotope-dilution mass spectrometry; multiple reaction monitoring; protein quantification; stable isotope-labeled internal standard peptides;
D O I
10.1586/14789450.3.6.597
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Over the decades, isotope-dilution mass spectrometry (IDMS) has been implemented extensively for accurate quantification of drugs, metabolites and peptides in body fluids and tissues. More recently, it has been extended for quantifying specific proteins in complex mixtures. In this extended methodology, proteins are subjected to endoprotease action and specific resultant peptides are quantified by using synthetic stable isotope-labeled standard (SIS) peptides and IDMS. This article outlines the utilities and applications of quantifying proteins by IDMS, emphasizing its complementary value to global survey-based proteomic studies. The potential of SIS peptides to provide quantitative insights into cell signaling is also highlighted, with specific examples. Finally, we propose several novel mass spectrometric data acquisition strategies for large-scale applications of IDMS and SIS peptides in systems biology and protein biomarker validation studies.
引用
收藏
页码:597 / 610
页数:14
相关论文
共 93 条
  • [71] ROACH PJ, 1991, J BIOL CHEM, V266, P14139
  • [72] Sensitive quantitative analysis of C-peptide in human plasma by 2-dimensional liquid chromatography-mass spectrometry isotope-dilution assay
    Rogatsky, E
    Balent, B
    Goswami, G
    Tomuta, V
    Jayatillake, H
    Cruikshank, G
    Vele, L
    Stein, DT
    [J]. CLINICAL CHEMISTRY, 2006, 52 (05) : 872 - 879
  • [73] The yeast nuclear pore complex: Composition, architecture, and transport mechanism
    Rout, MP
    Aitchison, JD
    Suprapto, A
    Hjertaas, K
    Zhao, YM
    Chait, BT
    [J]. JOURNAL OF CELL BIOLOGY, 2000, 148 (04) : 635 - 651
  • [74] Causal protein-signaling networks derived from multiparameter single-cell data
    Sachs, K
    Perez, O
    Pe'er, D
    Lauffenburger, DA
    Nolan, GP
    [J]. SCIENCE, 2005, 308 (5721) : 523 - 529
  • [75] IAP proteins: Blocking the road to death's door
    Salvesen, GS
    Duckett, CS
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2002, 3 (06) : 401 - 410
  • [76] Cytokine-inducible SH2 protein-3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain
    Sasaki, A
    Yasukawa, H
    Suzuki, A
    Kamizono, S
    Syoda, T
    Kinjyo, I
    Sasaki, M
    Johnston, JA
    Yoshimura, A
    [J]. GENES TO CELLS, 1999, 4 (06) : 339 - 351
  • [77] The role of c-FLIP in modulation of CD95-induced apoptosis
    Scaffidi, C
    Schmitz, I
    Krammer, PH
    Peter, ME
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (03) : 1541 - 1548
  • [78] CDK inhibitors:: positive and negative regulators of G1-phase progression
    Sherr, CJ
    Roberts, JM
    [J]. GENES & DEVELOPMENT, 1999, 13 (12) : 1501 - 1512
  • [79] Caspase activation: Revisiting the induced proximity model
    Shi, YG
    [J]. CELL, 2004, 117 (07) : 855 - 858
  • [80] PTEN: Life as a tumor suppressor
    Simpson, L
    Parsons, R
    [J]. EXPERIMENTAL CELL RESEARCH, 2001, 264 (01) : 29 - 41